0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PKB/Akt Kinase Activity Assay Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-1V17121
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PKB Akt Kinase Activity Assay Kit Market Research Report 2024
BUY CHAPTERS

Global PKB/Akt Kinase Activity Assay Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-1V17121
Report
November 2025
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PKB/Akt Kinase Activity Assay Kit Market Size

The global PKB/Akt Kinase Activity Assay Kit market is projected to grow from US$ 633 million in 2024 to US$ 952 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

PKB/Akt Kinase Activity Assay Kit Market

PKB/Akt Kinase Activity Assay Kit Market

The PKB/Akt Kinase Activity Assay Kit is an experimental tool used to detect the activity of intracellular protein kinase PKB (also known as Akt). PKB (Protein Kinase B, also known as Akt) is an important signal transduction protein kinase that plays an important role in cell growth, proliferation, survival and other processes. The PKB/Akt kinase activity assay kit can measure the activity level of PKB/Akt kinase through a specific biochemical reaction mechanism, usually based on detecting the phosphorylation level of its substrate. This kind of kit usually contains substrates, auxiliary reagents, probes, etc. for the reaction, and is equipped with detailed operating instructions. With this kit, researchers can quantitatively measure the activity level of PKB/Akt kinase to further understand its role and regulatory mechanism in cell signal transduction. This is of great significance for the study of cell signaling, disease mechanisms, and the development of new drugs.
The PKB/Akt kinase activity assay kit market is an important market segment in the field of biomedicine. Its development status and dynamics are jointly affected by multiple factors such as scientific research progress, market demand, and policy environment. With the continuous deepening of biomedical research, there is an increasing demand for research on PKB/Akt kinase activity. As a key molecule in cell signal transduction pathways, PKB/Akt plays an important role in many fields such as tumors, neurodegenerative diseases, and cardiovascular diseases. Therefore, the demand for PKB/Akt kinase activity assay kits has also shown continued growth, and the market also has broad development prospects.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global PKB/Akt Kinase Activity Assay Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of PKB/Akt Kinase Activity Assay Kit Market Report

Report Metric Details
Report Name PKB/Akt Kinase Activity Assay Kit Market
Accounted market size in 2024 US$ 633 million
Forecasted market size in 2031 US$ 952 million
CAGR 6.1%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Fluorescence Assay Kit
  • Other
Segment by Application
  • Biomedicine
  • Drug Discovery
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cell Signaling Technology, Abcam, Merck, Thermo Fisher Scientific, BioVision, Cayman Chemical, Santa Cruz Biotechnology, ApexBio Technology, Haohai Biological Technology, Enzo Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the PKB/Akt Kinase Activity Assay Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is PKB/Akt Kinase Activity Assay Kit Market growing?

Ans: The PKB/Akt Kinase Activity Assay Kit Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the PKB/Akt Kinase Activity Assay Kit Market size in 2031?

Ans: The PKB/Akt Kinase Activity Assay Kit Market size in 2031 will be US$ 952 million.

Who are the main players in the PKB/Akt Kinase Activity Assay Kit Market report?

Ans: The main players in the PKB/Akt Kinase Activity Assay Kit Market are Cell Signaling Technology, Abcam, Merck, Thermo Fisher Scientific, BioVision, Cayman Chemical, Santa Cruz Biotechnology, ApexBio Technology, Haohai Biological Technology, Enzo Life Sciences

What are the Application segmentation covered in the PKB/Akt Kinase Activity Assay Kit Market report?

Ans: The Applications covered in the PKB/Akt Kinase Activity Assay Kit Market report are Biomedicine, Drug Discovery, Other

What are the Type segmentation covered in the PKB/Akt Kinase Activity Assay Kit Market report?

Ans: The Types covered in the PKB/Akt Kinase Activity Assay Kit Market report are Fluorescence Assay Kit, Other

1 Study Coverage
1.1 Introduction to PKB/Akt Kinase Activity Assay Kit: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global PKB/Akt Kinase Activity Assay Kit Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Fluorescence Assay Kit
1.2.3 Other
1.3 Market Segmentation by Application
1.3.1 Global PKB/Akt Kinase Activity Assay Kit Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Drug Discovery
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PKB/Akt Kinase Activity Assay Kit Revenue Estimates and Forecasts 2020-2031
2.2 Global PKB/Akt Kinase Activity Assay Kit Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global PKB/Akt Kinase Activity Assay Kit Sales Estimates and Forecasts 2020-2031
2.4 Global PKB/Akt Kinase Activity Assay Kit Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global PKB/Akt Kinase Activity Assay Kit Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global PKB/Akt Kinase Activity Assay Kit Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Fluorescence Assay Kit Market Size by Manufacturers
3.5.2 Other Market Size by Manufacturers
3.6 Global PKB/Akt Kinase Activity Assay Kit Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global PKB/Akt Kinase Activity Assay Kit Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global PKB/Akt Kinase Activity Assay Kit Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global PKB/Akt Kinase Activity Assay Kit Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global PKB/Akt Kinase Activity Assay Kit Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Type (2020-2031)
6.4 North America PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America PKB/Akt Kinase Activity Assay Kit Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Type (2020-2031)
7.4 Europe PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe PKB/Akt Kinase Activity Assay Kit Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific PKB/Akt Kinase Activity Assay Kit Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Type (2020-2031)
9.4 Central and South America PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America PKB/Akt Kinase Activity Assay Kit Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa PKB/Akt Kinase Activity Assay Kit Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa PKB/Akt Kinase Activity Assay Kit Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cell Signaling Technology
11.1.1 Cell Signaling Technology Corporation Information
11.1.2 Cell Signaling Technology Business Overview
11.1.3 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.1.4 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit Sales by Product in 2024
11.1.6 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit Sales by Application in 2024
11.1.7 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit Sales by Geographic Area in 2024
11.1.8 Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit SWOT Analysis
11.1.9 Cell Signaling Technology Recent Developments
11.2 Abcam
11.2.1 Abcam Corporation Information
11.2.2 Abcam Business Overview
11.2.3 Abcam PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.2.4 Abcam PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abcam PKB/Akt Kinase Activity Assay Kit Sales by Product in 2024
11.2.6 Abcam PKB/Akt Kinase Activity Assay Kit Sales by Application in 2024
11.2.7 Abcam PKB/Akt Kinase Activity Assay Kit Sales by Geographic Area in 2024
11.2.8 Abcam PKB/Akt Kinase Activity Assay Kit SWOT Analysis
11.2.9 Abcam Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview
11.3.3 Merck PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.3.4 Merck PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Merck PKB/Akt Kinase Activity Assay Kit Sales by Product in 2024
11.3.6 Merck PKB/Akt Kinase Activity Assay Kit Sales by Application in 2024
11.3.7 Merck PKB/Akt Kinase Activity Assay Kit Sales by Geographic Area in 2024
11.3.8 Merck PKB/Akt Kinase Activity Assay Kit SWOT Analysis
11.3.9 Merck Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.4.4 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit Sales by Product in 2024
11.4.6 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit Sales by Application in 2024
11.4.7 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit Sales by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 BioVision
11.5.1 BioVision Corporation Information
11.5.2 BioVision Business Overview
11.5.3 BioVision PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.5.4 BioVision PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BioVision PKB/Akt Kinase Activity Assay Kit Sales by Product in 2024
11.5.6 BioVision PKB/Akt Kinase Activity Assay Kit Sales by Application in 2024
11.5.7 BioVision PKB/Akt Kinase Activity Assay Kit Sales by Geographic Area in 2024
11.5.8 BioVision PKB/Akt Kinase Activity Assay Kit SWOT Analysis
11.5.9 BioVision Recent Developments
11.6 Cayman Chemical
11.6.1 Cayman Chemical Corporation Information
11.6.2 Cayman Chemical Business Overview
11.6.3 Cayman Chemical PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.6.4 Cayman Chemical PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Cayman Chemical Recent Developments
11.7 Santa Cruz Biotechnology
11.7.1 Santa Cruz Biotechnology Corporation Information
11.7.2 Santa Cruz Biotechnology Business Overview
11.7.3 Santa Cruz Biotechnology PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.7.4 Santa Cruz Biotechnology PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Santa Cruz Biotechnology Recent Developments
11.8 ApexBio Technology
11.8.1 ApexBio Technology Corporation Information
11.8.2 ApexBio Technology Business Overview
11.8.3 ApexBio Technology PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.8.4 ApexBio Technology PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ApexBio Technology Recent Developments
11.9 Haohai Biological Technology
11.9.1 Haohai Biological Technology Corporation Information
11.9.2 Haohai Biological Technology Business Overview
11.9.3 Haohai Biological Technology PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.9.4 Haohai Biological Technology PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Haohai Biological Technology Recent Developments
11.10 Enzo Life Sciences
11.10.1 Enzo Life Sciences Corporation Information
11.10.2 Enzo Life Sciences Business Overview
11.10.3 Enzo Life Sciences PKB/Akt Kinase Activity Assay Kit Product Models, Descriptions and Specifications
11.10.4 Enzo Life Sciences PKB/Akt Kinase Activity Assay Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Enzo Life Sciences Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 PKB/Akt Kinase Activity Assay Kit Industry Chain
12.2 PKB/Akt Kinase Activity Assay Kit Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 PKB/Akt Kinase Activity Assay Kit Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 PKB/Akt Kinase Activity Assay Kit Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 PKB/Akt Kinase Activity Assay Kit Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global PKB/Akt Kinase Activity Assay Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global PKB/Akt Kinase Activity Assay Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global PKB/Akt Kinase Activity Assay Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global PKB/Akt Kinase Activity Assay Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global PKB/Akt Kinase Activity Assay Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global PKB/Akt Kinase Activity Assay Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global PKB/Akt Kinase Activity Assay Kit Sales by Region (2020-2025) & (Units)
 Table 8. Global PKB/Akt Kinase Activity Assay Kit Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global PKB/Akt Kinase Activity Assay Kit Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global PKB/Akt Kinase Activity Assay Kit Sales Share by Manufacturers (2020-2025)
 Table 12. Global PKB/Akt Kinase Activity Assay Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global PKB/Akt Kinase Activity Assay Kit Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global PKB/Akt Kinase Activity Assay Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PKB/Akt Kinase Activity Assay Kit as of 2024)
 Table 16. Global PKB/Akt Kinase Activity Assay Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global PKB/Akt Kinase Activity Assay Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers PKB/Akt Kinase Activity Assay Kit Manufacturing Base and Headquarters
 Table 19. Global PKB/Akt Kinase Activity Assay Kit Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global PKB/Akt Kinase Activity Assay Kit Sales by Type (2020-2025) & (Units)
 Table 23. Global PKB/Akt Kinase Activity Assay Kit Sales by Type (2026-2031) & (Units)
 Table 24. Global PKB/Akt Kinase Activity Assay Kit Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global PKB/Akt Kinase Activity Assay Kit Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global PKB/Akt Kinase Activity Assay Kit ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global PKB/Akt Kinase Activity Assay Kit Sales by Application (2020-2025) & (Units)
 Table 29. Global PKB/Akt Kinase Activity Assay Kit Sales by Application (2026-2031) & (Units)
 Table 30. PKB/Akt Kinase Activity Assay Kit High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global PKB/Akt Kinase Activity Assay Kit Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global PKB/Akt Kinase Activity Assay Kit Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global PKB/Akt Kinase Activity Assay Kit ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America PKB/Akt Kinase Activity Assay Kit Growth Accelerators and Market Barriers
 Table 37. North America PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America PKB/Akt Kinase Activity Assay Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe PKB/Akt Kinase Activity Assay Kit Growth Accelerators and Market Barriers
 Table 40. Europe PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe PKB/Akt Kinase Activity Assay Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Growth Accelerators and Market Barriers
 Table 45. Southeast Asia PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America PKB/Akt Kinase Activity Assay Kit Investment Opportunities and Key Challenges
 Table 47. Central and South America PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Cell Signaling Technology Corporation Information
 Table 51. Cell Signaling Technology Description and Major Businesses
 Table 52. Cell Signaling Technology Product Models, Descriptions and Specifications
 Table 53. Cell Signaling Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Cell Signaling Technology Sales Value Proportion by Product in 2024
 Table 55. Cell Signaling Technology Sales Value Proportion by Application in 2024
 Table 56. Cell Signaling Technology Sales Value Proportion by Geographic Area in 2024
 Table 57. Cell Signaling Technology PKB/Akt Kinase Activity Assay Kit SWOT Analysis
 Table 58. Cell Signaling Technology Recent Developments
 Table 59. Abcam Corporation Information
 Table 60. Abcam Description and Major Businesses
 Table 61. Abcam Product Models, Descriptions and Specifications
 Table 62. Abcam Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abcam Sales Value Proportion by Product in 2024
 Table 64. Abcam Sales Value Proportion by Application in 2024
 Table 65. Abcam Sales Value Proportion by Geographic Area in 2024
 Table 66. Abcam PKB/Akt Kinase Activity Assay Kit SWOT Analysis
 Table 67. Abcam Recent Developments
 Table 68. Merck Corporation Information
 Table 69. Merck Description and Major Businesses
 Table 70. Merck Product Models, Descriptions and Specifications
 Table 71. Merck Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Merck Sales Value Proportion by Product in 2024
 Table 73. Merck Sales Value Proportion by Application in 2024
 Table 74. Merck Sales Value Proportion by Geographic Area in 2024
 Table 75. Merck PKB/Akt Kinase Activity Assay Kit SWOT Analysis
 Table 76. Merck Recent Developments
 Table 77. Thermo Fisher Scientific Corporation Information
 Table 78. Thermo Fisher Scientific Description and Major Businesses
 Table 79. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 80. Thermo Fisher Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 82. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 83. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 84. Thermo Fisher Scientific PKB/Akt Kinase Activity Assay Kit SWOT Analysis
 Table 85. Thermo Fisher Scientific Recent Developments
 Table 86. BioVision Corporation Information
 Table 87. BioVision Description and Major Businesses
 Table 88. BioVision Product Models, Descriptions and Specifications
 Table 89. BioVision Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. BioVision Sales Value Proportion by Product in 2024
 Table 91. BioVision Sales Value Proportion by Application in 2024
 Table 92. BioVision Sales Value Proportion by Geographic Area in 2024
 Table 93. BioVision PKB/Akt Kinase Activity Assay Kit SWOT Analysis
 Table 94. BioVision Recent Developments
 Table 95. Cayman Chemical Corporation Information
 Table 96. Cayman Chemical Description and Major Businesses
 Table 97. Cayman Chemical Product Models, Descriptions and Specifications
 Table 98. Cayman Chemical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Cayman Chemical Recent Developments
 Table 100. Santa Cruz Biotechnology Corporation Information
 Table 101. Santa Cruz Biotechnology Description and Major Businesses
 Table 102. Santa Cruz Biotechnology Product Models, Descriptions and Specifications
 Table 103. Santa Cruz Biotechnology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Santa Cruz Biotechnology Recent Developments
 Table 105. ApexBio Technology Corporation Information
 Table 106. ApexBio Technology Description and Major Businesses
 Table 107. ApexBio Technology Product Models, Descriptions and Specifications
 Table 108. ApexBio Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. ApexBio Technology Recent Developments
 Table 110. Haohai Biological Technology Corporation Information
 Table 111. Haohai Biological Technology Description and Major Businesses
 Table 112. Haohai Biological Technology Product Models, Descriptions and Specifications
 Table 113. Haohai Biological Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Haohai Biological Technology Recent Developments
 Table 115. Enzo Life Sciences Corporation Information
 Table 116. Enzo Life Sciences Description and Major Businesses
 Table 117. Enzo Life Sciences Product Models, Descriptions and Specifications
 Table 118. Enzo Life Sciences Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Enzo Life Sciences Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. PKB/Akt Kinase Activity Assay Kit Product Picture
 Figure 2. Global PKB/Akt Kinase Activity Assay Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Fluorescence Assay Kit Product Picture
 Figure 4. Other Product Picture
 Figure 5. Global PKB/Akt Kinase Activity Assay Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Biomedicine
 Figure 7. Drug Discovery
 Figure 8. Other
 Figure 9. PKB/Akt Kinase Activity Assay Kit Report Years Considered
 Figure 10. Global PKB/Akt Kinase Activity Assay Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 12. Global PKB/Akt Kinase Activity Assay Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global PKB/Akt Kinase Activity Assay Kit Revenue Market Share by Region (2020-2031)
 Figure 14. Global PKB/Akt Kinase Activity Assay Kit Sales (2020-2031) & (Units)
 Figure 15. Global PKB/Akt Kinase Activity Assay Kit Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global PKB/Akt Kinase Activity Assay Kit Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Volume Market Share in 2024
 Figure 18. Global PKB/Akt Kinase Activity Assay Kit Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Fluorescence Assay Kit Revenue Market Share by Manufacturer in 2024
 Figure 21. Other Revenue Market Share by Manufacturer in 2024
 Figure 22. Global PKB/Akt Kinase Activity Assay Kit Sales Market Share by Type (2020-2031)
 Figure 23. Global PKB/Akt Kinase Activity Assay Kit Revenue Market Share by Type (2020-2031)
 Figure 24. Global PKB/Akt Kinase Activity Assay Kit Sales Market Share by Application (2020-2031)
 Figure 25. Global PKB/Akt Kinase Activity Assay Kit Revenue Market Share by Application (2020-2031)
 Figure 26. North America PKB/Akt Kinase Activity Assay Kit Sales YoY (2020-2031) & (Units)
 Figure 27. North America PKB/Akt Kinase Activity Assay Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) in 2024
 Figure 29. North America PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Type (2020- 2031)
 Figure 30. North America PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Application (2020-2031)
 Figure 32. North America PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe PKB/Akt Kinase Activity Assay Kit Sales YoY (2020-2031) & (Units)
 Figure 37. Europe PKB/Akt Kinase Activity Assay Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) in 2024
 Figure 39. Europe PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Type (2020-2031)
 Figure 40. Europe PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Application (2020-2031)
 Figure 42. Europe PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 44. France PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales YoY (2020-2031) & (Units)
 Figure 49. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Application (2020-2031)
 Figure 54. Asia-Pacific PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 59. India PKB/Akt Kinase Activity Assay Kit Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America PKB/Akt Kinase Activity Assay Kit Sales YoY (2020-2031) & (Units)
 Figure 61. Central and South America PKB/Akt Kinase Activity Assay Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Type (2021-2031)
 Figure 64. Central and South America PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Application (2020-2031)
 Figure 66. Central and South America PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa PKB/Akt Kinase Activity Assay Kit Sales YoY (2020-2031) & (Units)
 Figure 70. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Type (2021-2031)
 Figure 73. South America PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Sales Volume (Units) by Application (2020-2031)
 Figure 75. Middle East and Africa PKB/Akt Kinase Activity Assay Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa PKB/Akt Kinase Activity Assay Kit Revenue (2020-2025) & (US$ Million)
 Figure 80. PKB/Akt Kinase Activity Assay Kit Industry Chain Mapping
 Figure 81. Regional PKB/Akt Kinase Activity Assay Kit Manufacturing Base Distribution (%)
 Figure 82. Global PKB/Akt Kinase Activity Assay Kit Production Market Share by Region (2020-2031)
 Figure 83. PKB/Akt Kinase Activity Assay Kit Production Process
 Figure 84. Regional PKB/Akt Kinase Activity Assay Kit Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners